1Breiteneder-GeleffS, Soleiman A, Kowalski H, et al Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium[J]. Am J Pathol, 1999, 154(2): 385～394
2Wigle JT, Oliver G. Proxl function is required for the development of the murine lymphatic system [J]. Cell, 1999, 98 (6):769-778
3Banerji S, NiJ, Wang SX, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan[J].J Cell Biol, 1999, 144(4): 789- 801
4Valtola R, Salaven P, Heikkila P, et al. VEGFR-3 and its ligand VECF-C are associated with angiogenesis in breast cancer[J]. Am J Pathol, 1999, 154(5): 1381-1390
5Sawa Y, Kukaida A, Suzuki M, et al Identification of lymphatic vessels by using a monoclonal antibody specific for the human thoracic duct[J]. Microvascular Res, 1997, 53(2): 142-149
6Slayin SA, van den Abbeele AD, Losken A, et al. Return of lymphatic function after flap transfer for acute lymphedema [J]. Ann Surg, 1999, 229(3): 421-427
7Paavonen K, Puolakkainen P, Jussila L, et al. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing[J]. AmJ Pathol, 2000, 156(5): 1499-1504
8Liu NF, He QL. The regulatory effects of cytokines on lymphatic angiogenesis[J]. Lymphology, 1997, 30(1):3-12
9Jeltsch M, Kaipainen A, Joukov V, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice[J]. Science (Washington DC),1997, 276(5317): 1423-1425
10Joukov V, Kumar V, Sorsa T, et al. A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities[J]. J Biol Chem, 1998, 273(12):6599～6602
